Diamonds and Dogs
12/9/14
BlueBird Bio Inc. (BLUE)BlueBird Bio is flying high today, up 72.35% to $84.26. The clinical stage biopharmaceutical company saw its shares spike after positive news on its blood treatment. Management said that two patients with a killer blood disease have been able to forgo blood transfusions for at least five months after being treated with the company's technique to replace the defective gene that causes the condition. BlueBird's technique involves gene therapy, whereby corrected copies of defective genes are injected into patients own cells. Shares of BlueBird spiked over $35 today and set a new 52-week high of $85.48 intraday.
Conns Inc. (CONN)
Conns Inc. is crashing today, down 40.64% to $20.83. The furniture retailer saw its shares fall after missing on third quarter earnings caused by higher delinquency rates and Conn's CFO stepped down. Conn's offers financing to customers; some with low incomes and sub-par credit scores, and that segment of the business has taken a turn for the worse. Further hurting the company was CFO, Brian Taylor, announcing he would step down. Shares of Conns fell over $14 and set a new 52-week low of $19.57 intraday.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.